FCMI
Foresite Capital Management III Portfolio holdings
AUM
$37.9M
1-Year Return
6.87%
This Quarter Return
+22.47%
1 Year Return
-6.87%
3 Year Return
+443.49%
5 Year Return
+535.97%
10 Year Return
–
AUM
$363M
AUM Growth
+$56.9M
(+19%)
Cap. Flow
+$34.9M
Cap. Flow
% of AUM
9.63%
Top 10 Holdings %
Top 10 Hldgs %
84.78%
Holding
30
New
4
Increased
7
Reduced
6
Closed
10
Top Buys
| 1 |
MYOK
MyoKardia, Inc. Common Stock
MYOK
|
$12.6M |
| 2 |
AKAO
Achaogen, Inc.
AKAO
|
$10.6M |
| 3 |
XLRN
Acceleron Pharma Inc.
XLRN
|
$9.66M |
| 4 |
Ascendis Pharma
ASND
|
$9.52M |
| 5 |
ALDR
Alder Biopharmaceuticals, Inc.
ALDR
|
$9.37M |
Top Sells
| 1 |
FibroGen
FGEN
|
$8.08M |
| 2 |
LOXO
Loxo Oncology, Inc
LOXO
|
$5.76M |
| 3 |
Forte Biosciences
FBRX
|
$5.73M |
| 4 |
BLCM
Bellicum Pharmaceuticals, Inc.
BLCM
|
$5.29M |
| 5 |
DERM
Dermira, Inc.
DERM
|
$3.6M |
Sector Composition
| 1 | Healthcare | 49.78% |